Journal Information

Statistics

Follow this link to access the full text of the article

Brief Comunication
52-Week Mid-term Efficacy of Tildrakizumab in Moderate-to-severe Psoriasis: A Real-life Multicenter Experience
Eficacia a medio plazo (52 semanas) de tildrakizumab en el tratamiento de la psoriasis moderada a severa: un estudio multicéntrico de práctica clínica
F.J. Melgosa Ramosa,
Corresponding author
javimelgo@gmail.com

Corresponding author.
, A. Mateu Puchadesa, J. Matáix-Díazb, L. Schneller-Pavelescuc, I. Belinchón-Romerod, S. Santos Alarcóne
a Department of Dermatology, University Hospital Doctor Peset of Valencia, Valencia, Spain
b Department of Dermatology, Hospital Marina Alta, Vila-Joyosa, Alicante, Spain
c Department of Dermatology, Hospital de la Vega Baja, Orihuela, Alicante, Spain
d Department of Dermatology, General University Hospital of Alicante, Alicante, Spain
e Department of Dermatology, University Hospital Virgen de los Lirios, Alcoy, Alicante, Spain
Read
460
Times
was read the article
141
Total PDF
319
Total HTML
Share statistics
Article information
ISSN: 00017310
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2024 May 109 34 143
2024 April 210 107 317

Follow this link to access the full text of the article

Idiomas
Actas Dermo-Sifiliográficas
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?